Identification of a Kd-restricted antigenic peptide encoded by murine cytomegalovirus early gene M84

References

1. Azuma M., Cayabyab M., Buck D., Philipps J. H., Lanier L. L. 1992; CD28 interaction with B7 co-stimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. Journal of Experimental Medicine 175:353–360
   [Google Scholar]
2. Boppana S. B., Britt W. J. 1996; Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells. Virology 222:293–296
   [Google Scholar]
3. Borysiewicz L. K., Hickling J. K., Graham S., Sinclair J., Cranage M. P., Smith G. L., Sissons J. G. P. 1988; Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kDa immediate-early protein and glycoprotein B expressed by recombinant vaccinia viruses. Journal of Experimental Medicine 168:919–931
   [Google Scholar]
4. Chee M. S., Bankier A. T., Beck S., Bohni R., Brown C. M., Cerny R., Horsnell T., Hutchinson C. A.III., Kouzarides T., Martignetti J. A., Preddie E., Satchwell S. C., Tomlinson P., Weston K. M., Barrell B. G. 1990; Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Current Topics in Microbiology and Immunology 154:125–169
   [Google Scholar]
5. Cranmer L. D., Clark C. L., Morello C. S., Farrell E. H., Rawlinson W. D., Spector D. H. 1996; Identification, analysis, and evolutionary relationships of the putative murine cytomegalovirus homologs of the human cytomegalovirus UL82 (pp71) and UL83 (pp65) matrix phosphoproteins. Journal of Virology 70:7929–7939
   [Google Scholar]
6. Del Val M., Schlicht H.-J., Ruppert T., Reddehase M. J., Koszinowski U. H. 1991a; Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66:1145–1153
   [Google Scholar]
7. Del Val M., Schlicht H.-J., Volkmer H., Messerle M., Reddehase M. J., Koszinowski U. H. 1991b; Protection against lethal cytomegalovirus infection by a recombinant vaccine containing a single nonameric T-cell epitope. Journal of Virology 65:3641–3646
   [Google Scholar]
8. Eggers M., Boes-Fabian B., Ruppert T., Kloetzel P. M., Koszinowski U. H. 1995; The cleavage preference of the proteasome governs the yield of antigenic peptides. Journal of Experimental Medicine 182:1865–1870
   [Google Scholar]
9. Falk K., Rötzschke O., Stevanovic S., Jung G., Rammensee H.-G. 1991; Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290–296
   [Google Scholar]
10. Gonzales Armas J. C., Morello C. S., Cranmer L. D., Spector D. H. 1996; DNA immunization confers protection against murine cytomegalovirus infection. Journal of Virology 70:7921–7928
    [Google Scholar]
11. Hengel H., Brune W., Koszinowski U. H. 1998; Immune evasion by cytomegalovirus – survival strategies of a highly adapted opportunist. Trends in Microbiology 6:190–197
    [Google Scholar]
12. Holtappels R., Podlech J., Geginat G., Steffens H.-P., Thomas D., Reddehase M. J. 1998; Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates. Journal of Virology 72:7201–7212
    [Google Scholar]
13. Holtappels R., Thomas D., Podlech J., Geginat G., Steffens H.-P., Reddehase M. J. 2000; The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells. Journal of Virology 74:1871–1884
    [Google Scholar]
14. Kern F., Surel I. P., Faulhaber N., Frömmel C., Schneider-Mergener J., Schönemann C., Reinke P., Volk H.-D. 1999; Target structures of the CD8⁺ T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. Journal of Virology 73:8179–8184
    [Google Scholar]
15. Kleijnen M. F., Huppa J. B., Lucin P., Mukherjee S., Farrell H. E., Campbell A. E., Koszinowski U. H., Hill A. B., Ploegh H. L. 1997; A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO Journal 16:685–694
    [Google Scholar]
16. McLaughlin-Taylor E., Pande H., Forman S. J., Tanamachi B., Li C. R., Zaia J. A., Greenberg P. D., Riddell S. R. 1994; Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8⁺ virus-specific cytotoxic T lymphocytes. Journal of Medical Virology 43:103–110
    [Google Scholar]
17. Morello C. S., Cranmer L. D., Spector D. H. 1999; In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83. Journal of Virology 73:7678–7693
    [Google Scholar]
18. Morello C. S., Cranmer L. D., Spector D. H. 2000; Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65). Journal of Virology 74:3696–3708
    [Google Scholar]
19. Rammensee H.-G., Bachmann J., Stevanovic S. 1997 MHC ligands and peptide motifs. Molecular Biology Intelligence Unit Landes Bioscience, Austin, TX, USA:
    [Google Scholar]
20. Rawlinson W. D., Farrell H. E., Barrell B. G. 1996; Analysis of the complete DNA sequence of murine cytomegalovirus. Journal of Virology 70:8833–8849
    [Google Scholar]
21. Reddehase M. J. 2000; The immunogenicity of human and murine cytomegaloviruses. Current Opinion in Immunology 12:390–396
    [Google Scholar]
22. Reddehase M. J., Rothbard J. B., Koszinowski U. H. 1989; A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature 337:651–653
    [Google Scholar]
23. Retiere C., Prod’homme V., Imbert-Marcille B. M., Bonneville M., Vie H., Hallet M. M. 2000; Generation of cytomegalovirus-specific human T-lymphocyte clones by using autologous B-lymphoblastoid cells with stable expression of pp65 or IE1 proteins: a tool to study the fine specificity of the antiviral response. Journal of Virology 74:3948–3952
    [Google Scholar]
24. Utz U., Koenig S., Coligan J. E., Biddison W. E. 1992; Presentation of three different viral peptides, HTLV Tax, HCMV gB, and influenza virus M1, is determined by common structural features of the HLA-A2.1 molecule. Journal of Immunology 149:214–221
    [Google Scholar]
25. Wills M. R., Carmichael A. J., Mynard K., Jin X., Weekes M. P., Plachter B., Sissons J. G. P. 1996; The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. Journal of Virology 70:7569–7579
    [Google Scholar]
26. Ziegler H., Thäle R., Lucin P., Muranyi W., Flohr T., Hengel H., Farrell H., Rawlinson W., Koszinowski U. H. 1997; A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6:57–66
    [Google Scholar]